Meibomian Gland Dysfunction: Intense Pulsed Light Therapy in Combination with Low-Level Light Therapy as Rescue Treatment
June 2021
in “
Medicina
”
TLDR Combined light therapy improves eye health and quality of life for those with meibomian gland dysfunction.
This study evaluated the Eye-light® device, combining intense pulsed light therapy and low-level light therapy, for treating meibomian gland dysfunction (MGD) and dry eye disease (DED) in 22 eyes from 11 patients over 6 weeks. Significant improvements were observed in the Ocular Surface Disease Index (OSDI) score, meibomian gland dysfunction score, tear break-up time, lid margin vascularity, and gland orifice plugging. The treatment was found to be a beneficial adjunctive therapy, enhancing patients' quality of life without side effects. However, the study's retrospective design and lack of a control group were limitations, suggesting the need for further research.